Waltz Health is a technology company.
Waltz Health has raised $35.0M across 1 funding round.
Waltz Health has raised $35.0M in total across 1 funding round.
Waltz Health has raised $35.0M in total across 1 funding round.
Waltz Health's investors include 7wire Ventures, Define Ventures, General Catalyst, GV, Oak HC/FT, Optum Ventures, Sapphire Ventures, Slow Ventures, Threshold Ventures.
Waltz Health is a Chicago-based digital health technology company founded in 2021 that integrates AI-powered solutions into the pharmacy benefit process to enhance prescription drug affordability and access.[2][3] It builds products like the Marketplace Search application, which provides consumers with transparent drug pricing information, automatically delivering the lowest price at the pharmacy counter via benefits or cash-pay discounts, while filling data gaps for health plans and sponsors.[2] Serving millions across the U.S., including consumers, payers, pharmacies, and retailers, Waltz addresses the pervasive issue of prescription drug costs—impacting nearly 1 in 4 Americans—by partnering across the pharmaceutical supply chain to realign incentives and reduce prices.[2][3] The company has shown strong growth momentum, raising a $35M Series A in partnership with investors like Define Ventures, GV, and Echo Health Ventures, and recently merging with EVERSANA in August 2025 to bolster pharma commercialization capabilities.[1][3]
Waltz Health was founded in 2021 by Mark Thierer, a seasoned executive and former CEO of Catamaran (acquired by OptumRx for $13B), alongside a team with deep expertise in pharmacy benefit managers (PBMs).[2][3] The idea emerged from Thierer's intimate knowledge of the opaque pharmaceutical supply chain, where complex pricing burdens consumers, especially those with chronic conditions, leading to non-compliance and high costs.[3] Early traction came from launching Marketplace Search, an AI-driven tool that empowers users with pricing transparency and has scaled to serve millions nationwide, positioning Waltz as a neutral partner to all supply chain players.[2][3] A pivotal moment was joining the Pharmaceutical Care Management Association (PCMA) in February 2024, affirming its role in PBM innovation, followed by the $35M Series A and the transformative EVERSANA merger.[1][2][3]
Waltz Health stands out in the digital health space through these key strengths:
Waltz Health rides the wave of healthcare price transparency and AI-driven supply chain optimization, amplified by regulatory pushes like the U.S. push for drug pricing reforms and rising consumer demand amid 1-in-4 Americans struggling with med costs.[2][3] Timing is ideal post-2021 founding, aligning with PBM evolution, AI adoption in pharma, and post-pandemic focus on affordability, positioning it amid market forces like chronic disease prevalence and retailer margin pressures.[2][3] By joining PCMA and merging with EVERSANA, Waltz influences the ecosystem as a diversifying PBM innovator, promoting tools that lower costs for 266M+ insured lives while challenging opaque pricing—potentially reshaping how payers and pharmacies deliver value.[1][2]
Post-EVERSANA merger, Waltz is poised to accelerate with enhanced commercialization muscle, rolling out high-cost med solutions and expanding AI tools amid intensifying drug pricing scrutiny.[1][2] Trends like AI personalization in benefits, value-based care, and bipartisan affordability mandates will propel growth, evolving Waltz from a transparency disruptor to a dominant force in rewired pharma access.[2][3] Its supply chain neutrality and expert team signal outsized influence, potentially redefining consumer trust in prescriptions much like it started: by making life-saving drugs truly affordable.
Waltz Health has raised $35.0M across 1 funding round. Most recently, it raised $35.0M Series A in April 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2022 | $35.0M Series A | 7wire Ventures, Define Ventures, General Catalyst, GV, Oak HC/FT, Optum Ventures, Sapphire Ventures, Slow Ventures, Threshold Ventures |